tirzepatide pulled from market The for compounded GLP-1 drugs remained robust despite the end of semaglutide (Ozempic, Wegovy) and (Mounjaro, Zepbound) shortages, with many facilities adding ingredients like B vitamins and some operating with FDA facing blowback after ending

Patients starting at lower doses experienced slightly slower initial progress but equally impressive cumulative results, confirming that steady escalation achieves the same endpoint without unnecessary side effects

A useful tool for researchers and doctors, it distinguishes itself by integrating clinical symptoms, molecular explanations, and treatment implications in a balanced manner

A PROPRIETARY BLEND OF NATURAL INGREDIENTS INCLUDING BERBERINE, GLUTAMINE & TUMERIC

2025 Oct 6;15(1):366

Glucagon-like peptide receptor agonists (GLP-1RAs) and glucose-dependent insulinotropic polypeptide/glucagon-like peptide receptor agonists (GIP/GLP-1RAs) are two popularly prescribed pharmacological interventions, given their unprecedented efficacy in achieving long-term weight reductions in obesity and T2D patients

Novel imaging strategies There is a limited role for novel imaging strategies in routine clinical practice (strong)